Proton pump inhibitors and the risk of Clostridium difficile-associated disease: further evidence from the community.

Suppr

超能文献

作者信息

Cunningham Richard

机构信息

Department of Microbiology, Derriford Hospital, Plymouth, PL6 8DH, UK.

出版信息

CMAJ. 2006 Sep 26;175(7):757. doi: 10.1503/cmaj.060919.

DOI:10.1503/cmaj.060919

PMID:17001056

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1569916/

Abstract

摘要

相似文献

Proton pump inhibitors and the risk of Clostridium difficile-associated disease: further evidence from the community.

CMAJ. 2006 Sep 26;175(7):757. doi: 10.1503/cmaj.060919.

Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy.

CMAJ. 2006 Sep 26;175(7):745-8. doi: 10.1503/cmaj.060284.

Proton pump inhibitors and the risk for Clostridium difficile infection.

JAMA. 2009 Jul 1;302(1):31-2; author reply 32. doi: 10.1001/jama.2009.901.

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

JAMA. 2005 Dec 21;294(23):2989-95. doi: 10.1001/jama.294.23.2989.

Gastric acid-suppressive agents and risk of Clostridium difficile-associated disease.

JAMA. 2006 Jun 14;295(22):2599-600; author reply 2600-1. doi: 10.1001/jama.295.22.2599-b.

Diagnosis and management of patients with Clostridium difficile-associated diarrhoea.

Nurs Stand. 2007;21(46):49-56; quiz 58. doi: 10.7748/ns2007.07.21.46.49.c4589.

Risk of Clostridium difficile-associated disease among patients receiving proton-pump inhibitors in a Quebec medical intensive care unit.

Infect Control Hosp Epidemiol. 2007 Nov;28(11):1305-7. doi: 10.1086/521664. Epub 2007 Sep 18.

Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.

JAMA Intern Med. 2013 Jul 22;173(14):1359-67. doi: 10.1001/jamainternmed.2013.7056.

Increase in use of vancomycin for Clostridium difficile infection in US hospitals.

Infect Control Hosp Epidemiol. 2010 Aug;31(8):867-8. doi: 10.1086/655442.

Comorbidities, Exposure to Medications, and the Risk of Community-Acquired Clostridium difficile Infection: a systematic review and meta-analysis.

Infect Control Hosp Epidemiol. 2015 Feb;36(2):132-41. doi: 10.1017/ice.2014.39.

引用本文的文献

Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.

J Gastroenterol. 2018 Jan;53(1):84-94. doi: 10.1007/s00535-017-1369-3. Epub 2017 Jul 25.

Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study.

Mayo Clin Proc. 2012 Jul;87(7):636-42. doi: 10.1016/j.mayocp.2011.12.021.

本文引用的文献

Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy.

CMAJ. 2006 Sep 26;175(7):745-8. doi: 10.1503/cmaj.060284.

Clostridium difficile-associated diarrhea outbreaks: the name of the game is isolation and cleaning.

Clin Infect Dis. 2006 Mar 1;42(5):725; author reply 727-9. doi: 10.1086/500264.

Poor infection control, not fluoroquinolones, likely to be primary cause of Clostridium difficile-associated diarrhea outbreaks in Quebec.

Clin Infect Dis. 2006 Mar 1;42(5):725-7; author reply 727-9. doi: 10.1086/500268.

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

JAMA. 2005 Dec 21;294(23):2989-95. doi: 10.1001/jama.294.23.2989.

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

N Engl J Med. 2005 Dec 8;353(23):2442-9. doi: 10.1056/NEJMoa051639. Epub 2005 Dec 1.

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Clin Infect Dis. 2005 Nov 1;41(9):1254-60. doi: 10.1086/496986. Epub 2005 Sep 20.

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

CMAJ. 2004 Aug 31;171(5):466-72. doi: 10.1503/cmaj.1041104.

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.

CMAJ. 2004 Jul 6;171(1):33-8. doi: 10.1503/cmaj.1040876.

Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001.

J Infect Dis. 2004 May 1;189(9):1585-9. doi: 10.1086/383045. Epub 2004 Apr 20.

Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea.

J Hosp Infect. 2003 Jul;54(3):243-5. doi: 10.1016/s0195-6701(03)00088-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验